Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

NCT01124565 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Lateral Canthal Lines
Crow's Feet
Facial Wrinkles

Interventions

DRUG: RT001

Sponsor

Revance Therapeutics, Inc.